About the Authors

Holly G. Prigerson, Susan D. Block, Paul K. Maciejewski
Department of Psychiatry, Brigham and Women's Hospital, Boston, Massachusetts, United States of America

Holly G. Prigerson, Susan D. Block, Paul K. Maciejewski
Center for Psycho-Oncology and Palliative Care Research, Dana Farber Cancer Institute, Boston, Massachusetts, United States of America

Holly G. Prigerson, Susan D. Block
Harvard Medical School Center for Palliative Care, Boston, Massachusetts, United States of America

Mardi J. Horowitz
Department of Psychiatry, University of California School of Medicine, San Francisco, California, United States of America

Selby C. Jacobs
Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, United States of America

Colin M. Parkes
St. Christopher's Hospice, Sydenham, and St. Joseph's Hospice, Hackney, England

Mihaela Aslan
Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, United States of America

Karl Goodkin
Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center, Los Angeles, California, United States of America

Karl Goodkin
Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California, United States of America

Beverley Raphael
Department of Population Mental Health and Disasters, University of Western Sydney Medical School, New South Wales, Australia

Samuel J. Marwit
Department of Psychology, University of Missouri, St. Louis, Missouri, United States of America

Camille Wortman
Department of Psychology, State University of New York at Stony Brook, New York, United States of America

Robert A. Neimeyer
Department of Psychology, The University of Memphis, Memphis, Tennessee, United States of America

George Bonanno
Department of Counseling and Clinical Psychology, Teachers College, Columbia University, New York, New York, United States of America

David Kissane
Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, New York, New York, United States of America

Paul Boelen
Department of Clinical and Health Psychology, Utrecht University, Utrecht, The Netherlands

Andreas Maercker
Department of Clinical Psychology, University of Zürich, Zürich, Switzerland

Brett T. Litz
Veterans Affairs Boston Healthcare System, Boston, Massachusetts, United States of America

Brett T. Litz
National Center for PTSD, Boston, Massachusetts, United States of America

Brett T. Litz
Boston University School of Medicine, Boston, Massachusetts, United States of America

Jeffrey G. Johnson, Michael B. First
Department of Psychiatry, Columbia University, New York, New York, United States of America

Corresponding Author

Holly_Prigerson@dfci.harvard.edu

Competing Interests

MBF received consultant fees over the past 5 years from Roche, Corcept, Wyeth, Cephalon, Astra-Zeneca, Shire, GSK, and Eli Lilly for preparing diagnostic interviews and/or conducting diagnostic trainings at investigator meetings.

Author Contributions

ICMJE criteria for authorship read and met: HGP MJH SCJ CMP MA BR SJM CW KG RAN GB SDB DK PB AM BL JGJ MF PKM. Agree with the manuscript's results and conclusions: HGP MJH SCJ CMP MA BR SJM CW KG RAN GB SDB DK PB AM BL JGJ MF PKM. Designed the experiments/the study: HGP MJH PKM. Analyzed the data: PKM HGP MA. Collected data/did experiments for the study: HGP PKM. Enrolled patients: HGP. Wrote the first draft of the paper: HGP PKM. Contributed to the writing of the paper: HGP MJH SCJ CMP BR SJM CW RAN GB SDB DK PB AM JGJ MF PKM. Contributed to the conceptualisation: BR. Contributed items to the scale to assess PGD: CW. Assisted with interpretation of the results and contributed to the writing of the final manuscript, and reviewed and approved the contributions of others: RAN.